Search Result

Results for "

5)P2

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Biochemical Assay Reagents (10) Calcium Channel (2) Drug Derivative (3) Endogenous Metabolite (3) Fluorescent Dye (2) HCV (1) Interleukin Related (1) Isotope-Labeled Compounds (2) Liposome (1) MicroRNA (4) P2X Receptor (3) Phospholipase (2) PI3K (2) PI4K (2) PIKfyve (1) Sodium Channel (1)
By Research Areas:	Cancer (5) Cardiovascular Disease (2) Infection (1) Inflammation/Immunology (3) Metabolic Disease (9) Neurological Disease (2)
Oligonucleotides:	miRNA mimics (1) miRNA antagomirs (1) miRNA agomirs (1) MicroRNAs (4) miRNA inhibitors (1) Phospholipids (8)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Natural
Products

Isotope-Labeled Compounds

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-112461A

NF449 octasodium 4 Publications Verification	P2X Receptor	Cardiovascular Disease
NF449 octasodium is a highly potent P2X₁ receptor antagonist, with IC₅₀s of 0.28, 0.69, and 120 nM for rP2X₁, rP2X₁₊₅, P2X₂₊₃, respectively. NF449 octasodium is a G_sα-selective G Protein antagonist. NF449 octasodium suppresses the rate of GTP[γS] binding to G_sα-s, inhibits the stimulation of adenylyl cyclase activity, and blocks the coupling of β-adrenergic receptors to G_s .

HY-125118

GSK-A1 2 Publications Verification	PI4K HCV	Infection
GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC₅₀ of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC₅₀ of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research .

HY-15982

APY0201 5+ Cited Publications	PIKfyve Interleukin Related	Inflammation/Immunology
APY0201 is a potent PIKfyve inhibitor, which inhibits the conversion of PtdIns3P to PtdIns(3,5)P₂ in the presence of in the presence of [ ³³P]ATP with an IC₅₀ of 5.2 nM. APY0201 also inhibits IL-12/IL-23 production.

HY-115675

NC03	PI4K	Others
NC03 is a PI4K2A inhibitor and reducing agent. NC03 inhibits the activity of PI4K2A, thereby reducing the production of PI4P in the cellular compartments where PI4K2A functions. NC03 rapidly induces a decrease in PI4P pools in the Golgi and endosomal compartments. NC03 reduces PI4P production in Rab7-positive late endosomes .

HY-131615

TPC2-A1-P 4 Publications Verification	Sodium Channel	Others
TPC2-A1-P is a powerful and membrane permeable agonist of two pore channel 2 (TPC2) with an EC₅₀ of 10.5 μM. TPC2-A1-P plays its role by mimicking the physiological actions of PI(3,5)P2. TPC2-A1-P also shows higher potency to induce Na ²⁺ mobilisation from TPC2 than TPC-A1-N (HY-131614). TPC2-A1-P can be used to probe different functions of TPC2 channels in intact cells .

HY-131614

TPC2-A1-N Maximum Cited Publications 8 Publications Verification	Calcium Channel	Others
TPC2-A1-N is a powerful and Ca ²⁺-permeable agonist of two pore channel 2 (TPC2), which plays its role by mimicking the physiological actions of NAADP. TPC2-A1-P reproducibly evokes significant Ca ²⁺ responses from TPC2 (EC₅₀=7.8 μM), and the effect can be blocked by several TPC blockers. TPC2-A1-N can be used to probe different functions of TPC2 channels in intact cells .

HY-175067

*PtdIns-(4,5)-P2* (1,2-dihexanoyl) sodium salt** DHPI-4,5-P2 sodium salt; PI(4,5)P2 (6:0/6:0) sodium salt; PIP2[4',5'](6:0/6:0) sodium salt	Biochemical Assay Reagents	Others
PtdIns-(4,5)-P2 (1,2-dihexanoyl) (sodium salt) is a synthetic analog of natural Ptdlns with C₆:0 fatty acids at the sn-1 and sn-2 positions.

HY-112461

NF449	P2X Receptor	Cardiovascular Disease
NF449 is a highly potent P2X₁ receptor antagonist, with IC₅₀s of 0.28, 0.69, and 120 nM for rP2X₁, rP2X₁₊₅, P2X₂₊₃, respectively. NF449 is a G_sα-selective G Protein antagonist. NF449 suppresses the rate of GTP[γS] binding to G_sα-s, inhibits the stimulation of adenylyl cyclase activity, and blocks the coupling of β-adrenergic receptors to G_s .

HY-114457

Phosphatidylinositol 4,5-bisphosphate L-alpha-Phosphatidylinositol-4,5-bisphosphate; (PtdIns)-(4,5)-P2	Phospholipase	Inflammation/Immunology
Phosphatidylinositol 4,5-bisphosphate (L-alpha-Phosphatidylinositol-4,5-bisphosphate) is a plasma membrane lipid that is enriched in the cytoplasmic leaflet of the plasma membrane. Phosphatidylinositol 4,5-bisphosphate serves as a substrate for phospholipase C and class I PI3K, generating diacylglycerol, inositol (1,4,5)-trisphosphate, and phosphatidylinositol (3,4,5)-trisphosphate. Phosphatidylinositol 4,5-bisphosphate contributes to lamellipodial protrusion, directional cell migration, focal adhesion lipid generation, and trafficking of the GABA_A receptor. Phosphatidylinositol 4,5-bisphosphate can be used in research related to acute lung injury and pulmonary edema .

HY-172741

*Dioctanoyl PI(3,5)P2* sodium**	Drug Derivative	Metabolic Disease
Dioctanoyl PI(3,5)P2 sodium is a synthetic analog of PI(3,5)P2 (a natural phosphatidylinositol). Phosphatidylinositol phosphates (PIPs) are intracellular amphiphilic molecules implicated in numerous cellular responses including growth, division, movement, differentiation, neuro-exocytosis, and survival .

HY-150059

P2X7 receptor antagonist-2	P2X Receptor	Neurological Disease Inflammation/Immunology
P2X7 receptor antagonist-2 is a potent P2X7 receptor antagonist with a pIC₅₀ value of 6.5-7.5. P2X7 receptor antagonist-2 has efficacy of combating neuroinflammation .

HY-157712

*08:0 PI(4,5)P2* ammonium**	Biochemical Assay Reagents	Others
08:0 PI(4,5)P2 ammonium is suitable for identifying its binding site at the transient receptor potential vanilloid 4 (TRPV 4 N) terminus .

HY-149152

*PtdIns-(4,5)-P2* (1,2-dioctanoyl)**	Drug Derivative	Metabolic Disease
PtdIns-(4,5)-P2 (1,2-dioctanoyl) is a synthetic derivative of phosphatidylinositol.

HY-139926S

*PtdIns-(4,5)-P2* (1,2-dipamitoyl)-d62 trisodium**	Isotope-Labeled Compounds	Others
PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d₆₂ (trisodium) is the deuterium labeled PtdIns-(4,5)-P2 (1,2-dipamitoyl) trisodium .

HY-146835S

*(Rac)-16:0PI(3,5)P2-d5 ammonium*	Isotope-Labeled Compounds	Others
(Rac)-16:0PI(3,5)P2-d₅ (ammonium) is deuterium labeled (Rac)-16:0PI(3,5)P2 (ammonium).

HY-N15977

*18:1-6:0 Biotin PI(3,5)P2* ammonium）**	Biochemical Assay Reagents	Others
18:1-6:0 Biotin PI(3,5)P2 ammonium is a biotinylated lipid.

HY-RI02996A

*mmu-miR-3102-5p.2-5p antagomir*	MicroRNA	Cancer
mmu-miR-3102-5p.2-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-3102-5p.2-5p antagomir mmu-miR-3102-5p.2-5p antagomir

HY-171899A

Glycerophosphoinositol 4,5-diphosphate trisodium GroPI(4,5)P2 trisodium; GPIP2 trisodium	Calcium Channel	Others
Glycerophosphoinositol 4,5-diphosphate (GroPI(4,5)P2) trisodium is a slowly metabolized analog of InsP₃. Glycerophosphoinositol 4,5-diphosphate trisodium has an EC₅₀ of 1.228 μM for inducing calcium release, with a degradation time constant of 13 seconds. Glycerophosphoinositol 4,5-diphosphate trisodium can be used to study the effect of InsP₃ degradation on calcium signal recovery .

HY-157703

18:1 PI(4,5)P2 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium	Biochemical Assay Reagents
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-175386

D-myo-Inositol-4,5-diphosphate sodium Ins(4,5)-P2 sodium; 4,5-IP2 sodium	Endogenous Metabolite	Others
D-myo-Inositol-4,5-diphosphate (sodium) is one of the members in inositol phosphate family of second messengers that play an important role in transmitting cellular signals. D-myo-Inositol-4,5-diphosphate (sodium) can open calcium channels and increase intracellular calcium upon binding to its receptor on the endoplasmic reticulum .

HY-E70631

PIP5K1A Recombinant Human Active Lipid Kinase	PI3K	Cancer
PIP5K1A phosphorylates PI4P to synthesize the important signalling phospholipid PI(4,5)P2. This phospholipid also serves as the substrate for PI3K for conversion into PI(3,4,5)P3 to stimulate cell growth and survival. PIP5K1A has been directly implicated in breast cancer and prostate cancer. PIP5K1A Recombinant Human Active Lipid Kinase is a recombinant PIP5K1A protein that can be used to study PIP5K1A-related functions .

HY-148972

*PI(3,5)P2* diC16**	Liposome	Others
PI(3,5)P2 diC16 is a synthetic inositol phospholipid. PI(3,5)P2 diC16 is a lipid molecule .

HY-D3302

*PtdIns-(4,5)-P2-biotin sodium* DOPI-4,5-P2-biotin sodium; Phosphatidylinositol-4,5-diphosphate C-8-biotin sodium; PI(4,5)P2-biotin sodium	Biochemical Assay Reagents	Others
PtdIns-(4,5)-P2-biotin (DOPI-4,5-P2-biotin) sodium is a biotin-labeled phosphatidylinositol 4,5-bisphosphate (PIP2) derivative. PtdIns-(4,5)-P2-biotin sodium uses a biotin tag to capture and purify natural PIP2 molecules and their interacting proteins.

HY-175083

*PtdIns-(4,5)-P2-biotin trisodium*	Drug Derivative PI3K	Others
PtdIns-(4,5)-P2-biotin trisodium is a Biotin-labeled PtdIns-(4,5)-P2 analog. PtdIns-(4,5)-P2-biotin trisodium is an affinity probe of PI3Kγ. PI3Kγ can catalyse the phosphorylation of PtdIns-(4,5)-P2 at the 3′-OH group, giving rise to the second messenger PtdIns(3,4,5)-P3 .

HY-179554

*PtdIns-(4,5)-P2-fluorescein triethylammonium* PI(4,5)P2-fluorescein triethylammonium	Fluorescent Dye	Others
PtdIns-(4,5)-P2-fluorescein (PI(4,5)P2-fluorescein) triethylammonium is a fluorescently labeled phosphatidylinositol-4,5-bisphosphate, which is a marked form of an important phospholipid signaling molecule (PIP2) on the cell membrane. PtdIns-(4,5)-P2-fluorescein triethylammonium can be used to detect proteins that interact with phosphatidylinositol-4,5-bisphosphate, such as PI3K, PTEN, and PH domain proteins, etc .

HY-181446

*PtdIns-(4,5)-P2* (1,2-dipalmitoyl) ammonium**	Endogenous Metabolite	Others
PtdIns-(4,5)-P2 (1,2-dipalmitoyl) ammonium (PI(4,5)P2) is a signaling molecule. PtdIns-(4,5)-P2 (1,2-dipalmitoyl) ammonium is critical at multiple stages of endocytosis, where it sequentially recruits adaptor proteins and accessory proteins to endocytic sites. PtdIns-(4,5)-P2 (1,2-dipalmitoyl) ammonium is considered essential for maintaining the structure of the Golgi apparatus and the transport of proteins within the Golgi apparatus .

HY-172326

*DPPI-4,5-P2* ammonium**	Biochemical Assay Reagents Phospholipase	Others
DPPI-4,5-P2 ammonium is a sudstrate of Phosphoinositide-specific phospholipase C-δ1 (PI-PLC-δ1) .

HY-179898

*BODIPY TMR PI(4,5)P2* ester ammonium**	Biochemical Assay Reagents	Metabolic Disease
BODIPY TMR PI(4,5)P2 ester ammonium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

HY-N16001

*18:1-6:0 Biotin PI(4,5)P2* triammonium**	Biochemical Assay Reagents	Others
18:1-6:0 Biotin PI(4,5)P2 triammonium is a biotinylated lipid.

HY-R02996

*mmu-miR-3102-5p.2-5p mimic*	MicroRNA	Cancer
mmu-miR-3102-5p.2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-3102-5p.2-5p mimic mmu-miR-3102-5p.2-5p mimic

HY-176831

D-myo-Inositol-1,5-diphosphate sodium Ins(1,5)-P2 sodium; 1,5-IP2 sodium	Endogenous Metabolite	Others
D-myo-Inositol-1,5-diphosphate (Ins(1,5)-P2) sodium is a member of the inositol phosphate molecular family .

HY-RI02996

*mmu-miR-3102-5p.2-5p inhibitor*	MicroRNA	Cancer
mmu-miR-3102-5p.2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-3102-5p.2-5p inhibitor mmu-miR-3102-5p.2-5p inhibitor

HY-N16330

*14:0-6:0(C2 NBD) PI(4,5)P2* TEA**	Fluorescent Dye	Others
14:0-6:0(C2 NBD) PI(4,5)P2 TEA is a fluorescent lipid labeled with Nitrobenzoxadiazole (NBD) (Ex/Em = 460/540 nm).

HY-R02996A

*mmu-miR-3102-5p.2-5p agomir*	MicroRNA	Cancer
mmu-miR-3102-5p.2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-3102-5p.2-5p agomir mmu-miR-3102-5p.2-5p agomir

HY-172325

DPPI-5-P ammonium	Biochemical Assay Reagents	Others
DPPI-5-P (ammonium) (PtdIns-(5)-P₁) can be phosphorylated to form disphosphates such as PtdIns-(4,5)-P₂. DPPI-5-P (ammonium) can also be cleaved by PI-specific phospholipase C (PLC) to give inositol triphosphates .

HY-E70632

PIP5K1B Recombinant Human Active Lipid Kinase	Biochemical Assay Reagents	Neurological Disease
PIP5K1B participates in the biosynthesis of PI(4,5)P2. PIP5K1B is at the crossroad of different signaling pathways, mediating RAC1-dependent reorganization of actin filaments and contributing to the activation of phospholipase D2. PIP5K1B Recombinant Human Active Lipid Kinase can be used for the study of Friedreich’s ataxia (FRDA) .

*PtdIns-(4,5)-P2-biotin sodium* DOPI-4,5-P2-biotin sodium; Phosphatidylinositol-4,5-diphosphate C-8-biotin sodium; PI(4,5)P2-biotin sodium	Fluorescent Dye
PtdIns-(4,5)-P2-biotin (DOPI-4,5-P2-biotin) sodium is a biotin-labeled phosphatidylinositol 4,5-bisphosphate (PIP2) derivative. PtdIns-(4,5)-P2-biotin sodium uses a biotin tag to capture and purify natural PIP2 molecules and their interacting proteins.

Cat. No.	Product Name	Type

HY-157712

*08:0 PI(4,5)P2* ammonium**	Biochemical Assay Reagents
08:0 PI(4,5)P2 ammonium is suitable for identifying its binding site at the transient receptor potential vanilloid 4 (TRPV 4 N) terminus .

HY-157703

18:1 PI(4,5)P2 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium	Biochemical Assay Reagents
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-114457

Phosphatidylinositol 4,5-bisphosphate L-alpha-Phosphatidylinositol-4,5-bisphosphate; (PtdIns)-(4,5)-P2	Structural Classification Human Gut Microbiota Metabolites Classification of Application Fields Other Diseases Endogenous metabolite Disease Research Fields Lipid Source Classification	Phospholipase
Phosphatidylinositol 4,5-bisphosphate (L-alpha-Phosphatidylinositol-4,5-bisphosphate) is a plasma membrane lipid that is enriched in the cytoplasmic leaflet of the plasma membrane. Phosphatidylinositol 4,5-bisphosphate serves as a substrate for phospholipase C and class I PI3K, generating diacylglycerol, inositol (1,4,5)-trisphosphate, and phosphatidylinositol (3,4,5)-trisphosphate. Phosphatidylinositol 4,5-bisphosphate contributes to lamellipodial protrusion, directional cell migration, focal adhesion lipid generation, and trafficking of the GABA_A receptor. Phosphatidylinositol 4,5-bisphosphate can be used in research related to acute lung injury and pulmonary edema .

HY-N15977

*18:1-6:0 Biotin PI(3,5)P2* ammonium）**	Lipid	Biochemical Assay Reagents
18:1-6:0 Biotin PI(3,5)P2 ammonium is a biotinylated lipid.

HY-N16001

*18:1-6:0 Biotin PI(4,5)P2* triammonium**	Lipid	Biochemical Assay Reagents
18:1-6:0 Biotin PI(4,5)P2 triammonium is a biotinylated lipid.

HY-N16330

*14:0-6:0(C2 NBD) PI(4,5)P2* TEA**	Lipid	Fluorescent Dye
14:0-6:0(C2 NBD) PI(4,5)P2 TEA is a fluorescent lipid labeled with Nitrobenzoxadiazole (NBD) (Ex/Em = 460/540 nm).

Cat. No.	Product Name	Chemical Structure

HY-139926S

*PtdIns-(4,5)-P2* (1,2-dipamitoyl)-d62 trisodium**
PtdIns-(4,5)-P2 (1,2-dipamitoyl)-d₆₂ (trisodium) is the deuterium labeled PtdIns-(4,5)-P2 (1,2-dipamitoyl) trisodium .

HY-146835S

*(Rac)-16:0PI(3,5)P2-d5 ammonium*
(Rac)-16:0PI(3,5)P2-d₅ (ammonium) is deuterium labeled (Rac)-16:0PI(3,5)P2 (ammonium).

Cat. No.	Product Name		Classification

HY-157712

*08:0 PI(4,5)P2* ammonium**		Phospholipids
08:0 PI(4,5)P2 ammonium is suitable for identifying its binding site at the transient receptor potential vanilloid 4 (TRPV 4 N) terminus .

HY-RI02996A

*mmu-miR-3102-5p.2-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-3102-5p.2-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-157703

18:1 PI(4,5)P2 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium		Phospholipids
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-157713

*diC8PI(3,5)P2* triammonium** 08:0 PI(3,5)P2 triammonium		Phospholipids
diC8PI(3,5)P2 (08:0 PI(3,5)P2) triammonium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

HY-157643

*18:0-20:4 PI (4,5) P2* triammonium**		Phospholipids
18:0-20:4 PI (4,5) P2 triammonium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

HY-157649

*18:0-20:4 PI (3,5) P2* triammonium**		Phospholipids
18:0-20:4 PI (3,5) P2 triammonium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

HY-158572

*PtdIns-(4,5)-P2* (1,2-dipalmitoyl) trisodium**		Phospholipids
PtdIns-(4,5)-P2 (1,2-dipalmitoyl) (trisodium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.

HY-R02996

*mmu-miR-3102-5p.2-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-3102-5p.2-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI02996

*mmu-miR-3102-5p.2-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-3102-5p.2-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R02996A

*mmu-miR-3102-5p.2-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-3102-5p.2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-157685

*06:0 PI(3,5)P2* ammonium** PIP2[3',5'](6:0/6:0) ammonium		Phospholipids
06:0 PI(3,5)P2 (PIP2[3',5'](6:0/6:0)) ammonium is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

HY-157705

*18:1 PI(3,5)P2* triammonium** PIP2[3',5'](18:1(9Z)/18:1(9Z)) triammonium		Phospholipids
18:1 PI(3,5)P2 (triammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

5)P2

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

NaturalProducts

Isotope-Labeled Compounds

Oligonucleotides

Natural
Products